Atlas Trials

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Clinical trial NCT03778047 · COMPLETED

Trial details

NCT number
NCT03778047
Sponsor
Hinova Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration Resistant Prostate Cancer
Start date
2018-02-07
Primary completion
2018-10-24
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.